Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia - I. Involvement of interleukin-6

Human Genetics

Volumn 89, Issue 1, 1992, Pages 42-48

  Rosselli, F ^a   Sanceau, J ^a   Wietzerbin, J ^a   Moustacchi, E ^a  

^a INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 6; LYMPHOKINE; MITOMYCIN C; TUMOR NECROSIS FACTOR;

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; FANCONI ANEMIA; GENETIC DISORDER; HUMAN; HUMAN CELL; LYMPHOBLAST; PATHOGENESIS; PRIORITY JOURNAL;

CELL DIVISION; CELL LINE; CHROMOSOME ABERRATIONS; CULTURE MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FANCONI ANEMIA; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMAN; INTERLEUKIN-6; LYMPHOCYTES; MITOMYCIN; SUPPORT, NON-U.S. GOV'T; TUMOR NECROSIS FACTOR;

EID: 0026547984     PISSN: 03406717     EISSN: 14321203     Source Type: Journal    
DOI: 10.1007/BF00207040     Document Type: Article

References (28)

1. Role of lymphotoxin in expression of interleukin-6 in human fibroblasts. Stimulation and regulation
2. Cytokines: coordinators of immune and inflammatory responses
3. Susceptibility of Fanconi's anaemia fibroblasts to chromosome damage by carcinogens
4. Abnormal response to DNA crosslinking agents of Fanconi anemia fibroblasts can be corrected by transfection with normal human DNA
5. Partial complementation of the Fanconi anemia defect upon transfection by heterologous DNA: phenotypic dissociation of chromosomal and cellular hypersensitivity to DNA cross-linking agents
6. Identification of two complementation groups in Fanconi anemia
7. The cell cycle of lymphocytes in Fanconi anemia
8. Antioxidant status of Fanconi anemia fibroblasts
9. Isolation and characterization of mitomycin-C-sensitive mouse lymphoma cell mutants
10. Survival and mutagenic responses of mitomycin-C-sensitive mouse lymphoma cell mutants to other DNA cross-linking agents
11. Biological and clinical aspects of interleukin-6
12. Susceptibility of Fanconi's anemia lymphoblasts to DNA cross-linking and alkylating agents
13. Oxygen-dependence of chromosomal aberrations in Fanconi's anaemia
14. DNA semi-conservative synthesis in normal and Fanconi anemia fibroblasts following treatment with 8-methoxypsoralen and near ultraviolet light or with X-rays
15. Two complementation groups of Fanconi's anemia differ in their phenotypic response to a DNA-crosslinking treatment
16. Prevention of chromosomal breakage in Fanconi's anemia by cocultivation with normal cells
17. The fate of 8-methoxypsoralen photoinduced DNA interstrand-crosslinks in Fanconi's anemia cells of defined genetic complementation groups
18. Mutagenic response of Fanconi's anemia cells from a defined complementation group after treatment with photoactivated bifunctional psoralens
19. Hypomutability in Fanconi anemia cells is associated with increased deletion frequeny at the HPRT locus
20. Cocultivation of Fanconi anemia cells and of mouse lymphoma mutants leads to interspecies complementation of chromosomal hypersensitivity to DNA cross-linking agents
21. A high susceptibility of Fanconi's anemia to chromosome breakage by DNA-crosslinking agents
22. Spontane Chromosomen Aberrationen bei familiären Panmyelopathie
23. Interleukin-6: an overview
24. Purification and NH2-terminal amino acid sequence of a new T cell-derived lymphokine with growth factor activity for B cell hybridomas
25. Specific cellular defects in patients with Fanconi anemia
26. Antagonistic effect of cocultivation on mitomycin C-induced aberration rate in cells of a patient with Fanconi's anemia and in Chinese hamster ovary cells